NBD AI Bulletin - Shanghai Fosun Pharmaceutical (Group) Co Ltd (SH 600196, close price: 43.2 yuan) announced on June 24 that as at the day, the actual amount of external guarantees offered by the group was equivalent to about 22.795 billion yuan, representing about 58.16% of the group's audited net assets attributable to shareholders of the listed company as at December 31, 2021.

For 2021, the operating income of Shanghai Fosun Pharmaceutical (Group) Co Ltd mainly came from pharmaceutical manufacturing and R&D (74.1%), medical devices (15.22%), and medical services (10.56%).

As at the press time, the market value of Shanghai Fosun Pharmaceutical (Group) Co Ltd was 110.7 billion yuan.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.